• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗炎药物在对抗阿尔茨海默病中的作用。

Anti-inflammatory drugs in the fight against Alzheimer's disease.

作者信息

McGeer P L, McGeer E G

机构信息

Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada.

出版信息

Ann N Y Acad Sci. 1996 Jan 17;777:213-20. doi: 10.1111/j.1749-6632.1996.tb34421.x.

DOI:10.1111/j.1749-6632.1996.tb34421.x
PMID:8624086
Abstract

Lesions in Alzheimer disease are characterized by the assembly of a variety of cells and proteins associated with the immune system. Activated microglia express high levels of MHC glycoproteins and receptors for complement. Small numbers of T-lymphocytes infiltrate tissue. Proteins of the classical complement pathway are closely connected with beta-amyloid deposits. Several materials associated with senile plaques, including beta-amyloid protein itself, bind C1q in vitro and activate the pathway. The membrane attack complex of complement, as well as proteins which defend against that complex, colocalize with dystrophic neurites. These data imply that an autodestructive process is occurring in Alzheimer's disease, and that anti-inflammatory drugs might be an effective form of therapy. Some epidemiological evidence and results of a pilot clinical trial support this hypothesis.

摘要

阿尔茨海默病的病变特征是多种与免疫系统相关的细胞和蛋白质聚集。活化的小胶质细胞表达高水平的MHC糖蛋白和补体受体。少量T淋巴细胞浸润组织。经典补体途径的蛋白质与β-淀粉样蛋白沉积密切相关。几种与老年斑相关的物质,包括β-淀粉样蛋白本身,在体外与C1q结合并激活该途径。补体的膜攻击复合物以及抵御该复合物的蛋白质与营养不良性神经突共定位。这些数据表明,阿尔茨海默病正在发生自毁过程,抗炎药物可能是一种有效的治疗形式。一些流行病学证据和一项初步临床试验的结果支持这一假设。

相似文献

1
Anti-inflammatory drugs in the fight against Alzheimer's disease.抗炎药物在对抗阿尔茨海默病中的作用。
Ann N Y Acad Sci. 1996 Jan 17;777:213-20. doi: 10.1111/j.1749-6632.1996.tb34421.x.
2
Neuroimmune mechanisms in Alzheimer disease pathogenesis.
Alzheimer Dis Assoc Disord. 1994 Fall;8(3):149-58. doi: 10.1097/00002093-199408030-00001.
3
Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease.
Neurology. 1992 Feb;42(2):447-9. doi: 10.1212/wnl.42.2.447.
4
Pathological proteins in senile plaques.老年斑中的病理性蛋白质。
Tohoku J Exp Med. 1994 Nov;174(3):269-77. doi: 10.1620/tjem.174.269.
5
Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches.阿尔茨海默病中神经胶质介导的免疫炎症反应:补体激活与治疗方法
Neurobiol Aging. 1996 Sep-Oct;17(5):781-7. doi: 10.1016/0197-4580(96)00103-0.
6
Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
Am J Psychiatry. 1994 Aug;151(8):1105-13. doi: 10.1176/ajp.151.8.1105.
7
Immune system response in Alzheimer's disease.
Can J Neurol Sci. 1989 Nov;16(4 Suppl):516-27. doi: 10.1017/s0317167100029863.
8
Localization and cell association of C1q in Alzheimer's disease brain.C1q在阿尔茨海默病大脑中的定位及细胞关联
Exp Neurol. 1996 Mar;138(1):22-32. doi: 10.1006/exnr.1996.0043.
9
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.阿尔茨海默病的淀粉样蛋白假说:治疗之路上的进展与问题
Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994.
10
Targeting microglia for the treatment of Alzheimer's disease.以小胶质细胞为靶点治疗阿尔茨海默病。
Expert Opin Ther Targets. 2015 Apr;19(4):497-506. doi: 10.1517/14728222.2014.988707. Epub 2014 Nov 29.

引用本文的文献

1
Exploring the Neuroprotective and Neuropsychiatric Symptom Management Potential of Ketamine in Alzheimer's Disease.探索氯胺酮在阿尔茨海默病中的神经保护及神经精神症状管理潜力
Cureus. 2025 Jun 27;17(6):e86855. doi: 10.7759/cureus.86855. eCollection 2025 Jun.
2
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease.了解糖原合成酶激酶-3:阿尔茨海默病的新途径。
Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8.
3
Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen.
解读药物间比较中的获益与风险数据:以甲芬那酸与布洛芬为例说明挑战
Pharmaceutics. 2022 Oct 20;14(10):2240. doi: 10.3390/pharmaceutics14102240.
4
Mental health and periodontal and peri-implant diseases.心理健康与牙周病和种植体周围病。
Periodontol 2000. 2022 Oct;90(1):106-124. doi: 10.1111/prd.12452. Epub 2022 Aug 1.
5
Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.针对慢性炎症作为预防阿尔茨海默病策略的临床前狨猴模型
Vaccines (Basel). 2021 Apr 15;9(4):388. doi: 10.3390/vaccines9040388.
6
Avenanthramide-C Restores Impaired Plasticity and Cognition in Alzheimer's Disease Model Mice.燕麦氨酰胺-C 可恢复阿尔茨海默病模型小鼠受损的可塑性和认知能力。
Mol Neurobiol. 2020 Jan;57(1):315-330. doi: 10.1007/s12035-019-01707-5. Epub 2019 Jul 22.
7
The therapeutic role of minocycline in Parkinson's disease.米诺环素在帕金森病中的治疗作用。
Drugs Context. 2019 Mar 6;8:212553. doi: 10.7573/dic.212553. eCollection 2019.
8
Oil Palm Phenolics Inhibit the Aggregation of -Amyloid Peptide into Oligomeric Complexes.油棕酚类物质抑制β-淀粉样肽聚集成寡聚复合物。
Int J Alzheimers Dis. 2018 Jan 31;2018:7608038. doi: 10.1155/2018/7608038. eCollection 2018.
9
Methyl Salicylate Lactoside Protects Neurons Ameliorating Cognitive Disorder Through Inhibiting Amyloid Beta-Induced Neuroinflammatory Response in Alzheimer's Disease.水杨酸甲酯乳糖苷通过抑制阿尔茨海默病中淀粉样β诱导的神经炎症反应来保护神经元并改善认知障碍。
Front Aging Neurosci. 2018 Mar 27;10:85. doi: 10.3389/fnagi.2018.00085. eCollection 2018.
10
Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.阿尔茨海默病β淀粉样物质狨猴模型中炎症对淀粉样变性的加速作用
J Alzheimers Dis. 2017;55(1):101-113. doi: 10.3233/JAD-160673.